TotalMarketCap

PMGC

ELABNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.320 M

$1.63 -15.06%

Close of 6 Nov 2026

As of 6 Nov 2026, PMGC (ELAB) has a market capitalization of $1.32M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$590.1K

#3501 by revenue

Earnings

-$7.75M

Loss-making

Shares outstanding

8,095,793

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #491Lakewood-Amedex BiotherapeuticsLABT$1.42M
  2. #492Karyopharm TherapeuticsKPTI$1.40M
  3. #493PMGCELAB$1.32M
  4. #494Biodexa PharmaceuticalsBDRX$1.26M
  5. #495Artelo BiosciencesARTL$1.16M

What if PMGC were worth as much as…

Open the what-if tool →

Gold $28.2T

$34,878,478

Per share 21,387,342× higher

Bitcoin $1.53T

$1,887,214

Per share 1,157,232× higher

Apple $5.02T

$6,195,546

Per share 3,799,084× higher

Or at a round number

$2.00M$5.00M$10.0M$20.0M

Where these numbers come from

Share counts and financials for PMGC are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.